logowsbdaily | Wed, 10 Aug 2022 07:32:32 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

Evofem Biosciences, Inc.
(EVFM)

Evofem Biosciences, Inc.
12400 High Bluff Drive
Suite 600
San Diego, CA 92130
United States
858 550 1900
www.evofem.com
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Summary & Charts

Price$ 0.62-0.18 (-22.5%)
Day's Range$ 0.58 - 0.76 
Previous Close$ 0.80
Market Cap$ 22.08M USD
Short Interest %22.9 %As of Fri, 15 Jul 2022
Float37.92M
Outstanding42.2M
ExchangeNasdaqCM
IndustryBiotechnology
SectorHealthcare
Volume24.98M
Avg. Volume (20 day)20.93M
Rel. Volume (20 day)1.19
Rel. Volume (3 month)0.75
RatingBNeutral
DCFN/AStrong Buy
Debt/Equity-126.99 %Sell
ROE275.18 %Buy
ROA-552.28 %Strong Sell
P/E-0.04 %Neutral
P/B-0.05 %Neutral
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Aug 09, 2022$ 0.75$ 0.76$ 0.58$ 0.62-0.1824,982,6831.190.752
Aug 08, 2022$ 0.92$ 0.93$ 0.79$ 0.80-0.1418,374,9730.880.561
Aug 05, 2022$ 1.05$ 1.11$ 0.90$ 0.94+0.0539,256,3511.811.243
Aug 04, 2022$ 0.88$ 0.93$ 0.82$ 0.90+0.0319,246,7450.850.634
Aug 03, 2022$ 0.76$ 0.91$ 0.76$ 0.87+0.1016,426,7660.610.55
Aug 02, 2022$ 0.74$ 0.81$ 0.72$ 0.77-0.017,297,6460.220.25
Aug 01, 2022$ 0.73$ 0.80$ 0.71$ 0.77+0.047,755,4120.220.27
Jul 29, 2022$ 0.85$ 0.87$ 0.72$ 0.73-0.0115,060,2870.400.521
Jul 28, 2022$ 0.75$ 0.77$ 0.70$ 0.74-0.059,301,9160.220.33
Jul 27, 2022$ 0.81$ 0.82$ 0.74$ 0.79-0.0410,310,1160.220.37
Jul 26, 2022$ 0.85$ 0.85$ 0.80$ 0.83-0.038,377,9580.130.31
Jul 25, 2022$ 0.88$ 0.94$ 0.83$ 0.86+0.0014,313,9970.160.521
Jul 22, 2022$ 0.98$ 1.00$ 0.85$ 0.86-0.1422,572,8900.250.822
Jul 21, 2022$ 0.89$ 1.08$ 0.85$ 1.00+0.1765,256,0410.732.372
Jul 20, 2022$ 0.85$ 0.91$ 0.81$ 0.83+0.0219,146,5570.220.711
Jul 19, 2022$ 0.87$ 0.92$ 0.80$ 0.81-0.0715,522,9600.180.572
Jul 18, 2022$ 0.77$ 1.04$ 0.75$ 0.88+0.0040,248,6440.471.472
Jul 15, 2022$ 1.04$ 1.05$ 0.84$ 0.88-0.1933,197,7090.401.226
Jul 14, 2022$ 1.13$ 1.14$ 1.04$ 1.07-0.0812,955,7770.160.482
Jul 13, 2022$ 1.17$ 1.30$ 1.13$ 1.15-0.0918,921,8640.230.694

News

The latest news about Evofem Biosciences, Inc. (EVFM).

PennyStocks | 2022-08-05 06:00:00
Penny Stocks to Buy Premarket on August 5th? 3 to Watch
Here's what you need to know about buying penny stocks on August 5th? The post Penny Stocks to Buy Premarket on August 5th?
Seeking Alpha | 2022-08-04 23:27:10
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q2 2022 Results - Earnings Call Transcript
Evofem Biosciences, Inc. (NASDAQ:EVFM ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Amy Raskopf - Vice President-Investor Relations Saundra Pelletier - Chief Executive Officer, President and Executive Director Jay File - Chief Financial Officer Katherine Atkinson - Chief Commercial Officer Conference Call Participants David Amsellem - Piper Sandler Yale Jen - Laidlaw and Company Stacy Lee - Stifel Ram Selvaraju - H.C. Wainwright Operator Good afternoon.
PRNewsWire | 2022-07-28 08:47:00
Evofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022
-- Conference Call Scheduled for 5:00 p.m. ET -- SAN DIEGO , July 28, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the second quarter ended June 30, 2022 as follows: Date: Thursday, August 4, 2022 Time: 5:00 pm.
PennyStocks | 2022-07-13 10:49:14
Penny Stocks To Buy? 4 Short Squeeze Stocks To Watch After CPI Data
Short squeeze penny stocks to watch right now. The post Penny Stocks To Buy?
PennyStocks | 2022-07-12 07:00:00
What to Know About Buying Penny Stocks on July 12th
Here's what you need to know about trading penny stocks on July 12th The post What to Know About Buying Penny Stocks on July 12th appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
InvestorPlace | 2022-07-06 18:36:39
A Market Breakout is Coming
A huge battle playing out between the bulls and bears … so much rests on Q2 earnings … get ready for a month of important data releases The markets are setting up for a dramatic breakout – the question is: “In which direction?” Either the bears are overly pessimistic, and the next few months will.
InvestorPlace | 2022-07-06 11:42:55
Is Evofem Biosciences (EVFM) Stock the Next Big Squeeze?
Fintel has ranked Evofem Biosciences as the next top gamma squeeze. Will Meade noticed.

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2022-08-04AMC------6M----
2022-05-10AMC-3----4.3M4.3M--
2022-03-03AMC-0.23-0.3343.47%4.2M3.6M-13.98%
2021-11-15AMC-0.29-0.4865.51%1.5M1.7M17.17%
2021-08-11AMC-0.35-0.2722.86%2.7M1.9M-30.71%
2021-05-06AMC-0.49-0.5614.28%1.6M1.1M-32.21%
2021-03-04AMC-0.36-0.5038.88%1.7M168K-90.06%
2020-11-09AMC-0.44-0.3715.91%322K278K-13.73%

Due Diligences

These posts should include more in-depth research by the poster about the specific company, sector or trade idea. Including any sources and citations.

EVFM - Phexxi - the Tesla or Moderna of sex? revolutionary if STI indication approved

Not financial advice. Do your own DD. I'm a dumb ass and I've lost a lot of money this year chasing things. Don't gamble, if you have a gambling problem seek help. 1 (800) 522-4700 $EVFM FDA approved for birth control but wait there's more! STI (std) prevention indication - if phase 3 trial... Read More

17 comments | 49 votes

Top Discussions

These are the top discussions over the last 24-hours that mention the EVFM stock ticker symbol.

Evofem (NASDAQ: EVFM) about to squeeze? 30% of the float short CTB is 150%+ Hot product with sales ramping up

**Reproductive Rights, Birth Control and Sexual Health are Hot Topics in America and Evofem (EVFM) is a Big Part of That Discussion** **EVFM has a contraceptive that is hormone free, used on demand, ... Read More


Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Tue, 14 Dec 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.